about
Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesisSubclinical hypercortisolism: a state, a syndrome, or a disease?Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R.Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma.ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesSteroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronismCBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.Aged PROP1 deficient dwarf mice maintain ACTH production.Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.Isoenergetic feeding of low carbohydrate-high fat diets does not increase brown adipose tissue thermogenic capacity in ratsSomatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.Deficits in the management of patients with adrenocortical carcinoma in Germany.Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone.Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.Ectopic pro-opiomelanocortin syndrome.Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.Virilization of a young girl caused by concomitant ectopic and intra-adrenal adenomas of the adrenal cortex.Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.Animal models of adrenocortical tumorigenesisThe Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma.Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects.Adrenocortical tumorigenesis.Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expressionAdrenal incidentalomas: presentation and clinical work-up.Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone productionThe diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn RegistryThe tumor stem cell concept-implications for endocrine tumors?Adrenal cortical insufficiency--a life threatening illness with multiple etiologies.Role of bone morphogenetic proteins in adrenal physiology and disease.Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translationMouse models of adrenal tumorigenesis.Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates.Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry.Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.Regulation of aldosterone secretion: from physiology to disease.Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review.
P50
Q24311802-83B9152B-EACC-4DF6-AA00-30F07797A6BAQ26797475-392E5D9B-2475-4082-BF37-A56902D0AACAQ28594777-F41A094F-78BE-4DAC-9849-B579E8AB9DFEQ33308954-6A1B1901-32D5-4F20-8353-C228B562E608Q33460907-1B9CB710-6024-4009-9F86-7F8C6460B3DEQ33570265-39A66631-FE9A-46D0-85A3-7BE077C2C0A5Q33579003-07D959F5-5169-473B-8E3A-71788B206A64Q33623390-4465DD28-0103-42DD-9942-401155A63128Q34092471-244710F1-D1DE-47E0-A0C8-3C8DE906D8A9Q34276843-1812BD05-1EBA-4F8D-AFDA-CCF839E38E27Q34284740-75474655-377C-426C-BC6E-3FCC905EA84AQ34312049-FFBFCFF9-92AD-409B-B2DC-7125CF54F4ABQ34328209-8C696D90-4F5E-4BA0-967A-C00B3A1740F9Q34495638-49862D20-6BCD-4049-9A63-E8776E1D719FQ34583878-6882CDD5-8863-48C4-85DA-12EECF5AE0E1Q34586245-BCB85516-E6DF-4B8D-92D3-3AD564B594DBQ34677258-F7DEC2BE-156B-461F-B6B4-8A8D411FBFF4Q34677263-F2B794F8-0F1A-49FB-9D09-D661176AE7CFQ34742551-4CC14CB4-F21F-44B1-8792-96FCC95831CCQ35002304-CFCE78EA-5631-443F-B272-E7932F1DBB63Q35784857-C99242FB-3FFC-4C11-B45A-0582DA454A01Q35813265-644CDA61-7908-4213-ADC4-986BDAB2A583Q36503929-BADDE0FC-3E37-4A35-840D-28EFCB8D55DBQ36535881-39A21AA9-29E4-41C9-8A78-B67A282D780AQ36685485-DC193CEC-3B12-48C3-A2CA-1C7790F45C63Q36694025-5848AA11-A073-44E2-AA35-0C2E5B2FFEB2Q37015016-F4A7B280-3E46-4ACB-9F90-EEA17E9B2CE7Q37050125-C145A3FB-590A-4BCC-92EC-FD4F9D5F33C7Q37088867-1A5062CA-75F4-4745-85F6-03AA6E94E9C7Q37210382-A4A22608-4DE1-43F3-BD66-8E2F728CFFDBQ37332788-EA6C644E-CBAD-4360-A294-E7C5DBF6D11BQ37592058-DAF9B45C-418B-4028-91BB-62D5B9953EC0Q37687678-6D5A5B38-E2E1-4B68-B5AB-AE23D24A15B3Q37694784-0AD47882-82D6-49BD-BEDE-427EFD057BCCQ37813227-284B1105-9B2C-4A94-B8CB-80395EF009ECQ37878176-DF1CC7E7-30D6-40A9-A18C-7B52A82F3482Q37940548-5B82EBF1-0FF9-4D72-9A71-C87DEEF01DF7Q38034749-5FACB2E9-473F-49B9-B195-EF838CC68370Q38097369-A8FB39B2-F75F-4A6B-89C8-27DA32B0342AQ38129854-10B29FBD-CC29-4053-8316-CA9EF74EC034
P50
description
Endocrinologist
@en
onderzoeker
@nl
taighdeoir
@ga
հետազոտող
@hy
name
Felix Beuschlein
@ast
Felix Beuschlein
@de
Felix Beuschlein
@en
Felix Beuschlein
@es
Felix Beuschlein
@fr
Felix Beuschlein
@nl
Felix Beuschlein
@sl
type
label
Felix Beuschlein
@ast
Felix Beuschlein
@de
Felix Beuschlein
@en
Felix Beuschlein
@es
Felix Beuschlein
@fr
Felix Beuschlein
@nl
Felix Beuschlein
@sl
prefLabel
Felix Beuschlein
@ast
Felix Beuschlein
@de
Felix Beuschlein
@en
Felix Beuschlein
@es
Felix Beuschlein
@fr
Felix Beuschlein
@nl
Felix Beuschlein
@sl
P214
P227
P101
P106
P21
P213
0000 0000 1283 7546
P214
P227
P2798
P31
P496
0000-0001-7826-3984
P569
1969-01-01T00:00:00Z
P735
P7859
viaf-74683492